药物信息为DARAPRIM (pyrimethamine) 25-mg Scored Tablets (GlaxoSmithKline): REFERENCES
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- CONTRAINDICATIONS
- WARNINGS
- ADVERSE REACTIONS
- OVERDOSAGE
- HOW SUPPLIED
- REFERENCES
- Diseases/Conditions Related to DARAPRIM (pyrimethamine) 25-mg Scored Tablets (GlaxoSmithKline)
- 外部链接相关的DARAPRIM (pyrimethamine) 25-mg Scored Tablets (GlaxoSmithKline)
- Eyles DE, Coleman N. Synergistic effect of sulfadiazine and Daraprim against experimental toxoplasmosis in the mouse. Antibiot Chemother. 1953;3:483-490.
- Jacobs L, Melton ML, Kaufman HE. Treatment of experimental ocular toxoplasmosis. Arch Ophthalmol. 1964;71:111-118.
- Jim RTS, Elizaga FV. Development of chronic granulocytic leukemia in a patient treated with pyrimethamine. Hawaii Med J. 1977;36:173-176.
- Sadoff L. Antimalarial drugs and Burkitt’s lymphoma. Lancet. 1973;2:1262-1263.
- Bahna L. Pyrimethamine. LARC Monogr Eval Carcinog Risk Chem. 1977;13:233-242.
- Clive D, Johnson KO, Spector JKS, et al. Validation and characterization of the L5178Y/TK +/- mouse lymphoma mutagen assay system. Mut Res. 1979;59:61-108.
Manufactured by
DSM Pharmaceuticals, Inc.
Greenville, NC 27834 for
GlaxoSmithKline
Research Triangle Park, NC 27709
©2003, GlaxoSmithKline. All rights reserved.
RL-1179
- Drug Information Provided by National Library of Medicine (NLM).
